The  pharmaceutical grade sodium chloride market was USD 350 million in 2022 and is anticipated to reach USD 591.32 million by 2032, growing at a CAGR of 6% during the forecast period. Increasing demand for intravenous sodium chloride solutions, growing prevalence of chronic diseases, and adoption of innovative manufacturing techniques in the pharmaceutical industry are the main drivers of the market's revenue growth. Pharmaceutical grade sodium chloride is frequently used as an excipient in intravenous solutions for medical purposes, such as medication delivery, wound care, and hydration treatment. The demand for intravenous solutions is increasing due to the rise in chronic diseases like diabetes, cancer, and cardiovascular illnesses, which is in turn driving the revenue growth of the pharmaceutical grade sodium chloride market.

Get a free sample PDF of the report, visit @

Furthermore, the pharmaceutical industry's increasing use of sterile manufacturing techniques, such as continuous manufacturing, is driving the demand for pharmaceutical grade sodium chloride. The use of premium raw materials, such as pharmaceutical grade sodium chloride, is required in sterile production methods to ensure the safety and quality of the final product.

To know more about the latest insights of the report, visit @

The rising demand for improved wound care solutions is also driving the need for pharmaceutical grade sodium chloride in wound care applications. Additionally, the increased emphasis on customized medicine and the expansion of Contract Manufacturing Organizations (CMOs) are driving the need for superior pharmaceutical grade sodium chloride.

However, the market's revenue growth is expected to be constrained by factors such as the availability of substitute products, fluctuating raw material prices, and strict regulatory standards governing the manufacturing and use of pharmaceutical grade sodium chloride.

Request a customized copy of the report @

The global pharmaceutical grade sodium chloride market has been segmented into product types, including oral grade, injectable grade, topical grade, and others. The oral grade segment is anticipated to hold the largest revenue share during the forecast period, driven by the increasing demand for oral pharmaceuticals such as tablets and capsules. The injectable grade segment is expected to witness the fastest revenue growth rate during the forecast period due to the growing need for sodium chloride in the manufacturing of injectable medicines, while the topical grade segment is expected to register a rapid revenue growth rate due to the increasing demand for topical treatments. The market has also been segmented into applications, including oral rehydration salts, hemodialysis, infusion, and others. The infusion segment is expected to hold the largest revenue share during the forecast period, driven by the widespread use of infusion solutions to treat various medical illnesses.

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.


John W, Head of Business Development
Reports And Data | Web:
Direct Line: +1-212-710-1370
LinkedIn | Twitter | Blogs

Browse for more reports…